4basebio Stock
Detail | Data |
---|---|
Volume (24h): | 3 shares |
P/E Ratio: | / |
Forward P/E: | -0.20 |
EPS: | -0.78 GBp |
Forward EPS: | -60 GBp |
Number of Shares: | 15,471,900 shares |
Market Capitalization: | 184,522,160.00 GBp |
Dividend
Dividend | Value |
---|---|
Dividend Amount | According to our data, the company 4basebio does not currently pay dividends. |
Annual Yield %: | - |
Ex-dividend Date: | - |
5-Year Avg Yield %: | - |
Payout Ratio: | - |
Last Dividend Value: | - |
Last Dividend Date: | - |
Analyst Forecast
Analysts | Recommendation |
---|---|
Issued Recommendation: | According to our data, the recommendation for 4basebio stock is: buy |
Number of Analysts: | 2 |
Highest Target Price: | 1800 GBp |
Lowest Target Price: | 1600 GBp |
Median Target Price: | 1700 GBp |
Fundamental Indicators
Indicator | Data |
---|---|
Total Revenue: | 596,000.00 GBp |
Net Income: | -9,838,000.00 GBp |
Price-to-Book (P/B): | / |
PEG Ratio: | / |
Exchange: | LSE |
Industry: | Biotechnology |
Sector: | Healthcare |
Number of Employees: | 101 |
Country: | United Kingdom |
Where to Buy 4basebio Stock?
You can purchase 4basebio stock on the LSE under the ticker symbol: 4BB.L. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.
Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.
More Information on 4basebio Stock
Indicator | Value |
---|---|
Company Revenue: | 596,000.00 GBp |
EBITDA: | -9,633,000.00 GBp - Negative EBITDA may signal financial challenges or growth investments. |
Earnings Per Share: | -0.78 GBp |
Book Value Per Share: | -0.41 GBp |
Total Cash: | 2,718,000.00 GBp |
Total Cash per Share: | 0.21 GBp |
Total Debt: | 15,494,000.00 GBp |
Debt to Equity Ratio: | - |
Quick Ratio | 1.54 |
Current Ratio | 2.73 |
Free Cash Flow | -7,063,500.00 GBp |
Operating Cash Flow | -8,332,000.00 GBp |
Gross Margins | 69.63 % |
EBITDA Margins | - |
Operating Margins | -1,767.99 % |
Profit Margins | - |
Return on Assets | -54.3 % |
Return on Equity | - |
Earnings Growth (1 year) | - |
Revenue Growth (1 year) | 37.8 % |
Quarterly Earnings Year-over-Year Growth | - |
Market Capitalization | 184,522,160.00 GBp |
Enterprise Value | 163,877,456.00 GBp |
EV/Revenue | 274.962 |
EV/EBITDA | -17.012 |
Float Shares | 5,375,370 shares |
Shares Outstanding | 15,471,900 shares |
Held Percent Insiders | 0.61 % |
Held Percent Institutions | 14.19 % |
Shares Short | - |
Shares Short Prior Month | - |
Date Short Interest | - |
Short Percentage of Total Shares | - |
Short Ratio | - |
Beta | 1.09 |
Short Percentage of Float | - |
Implied Shares Outstanding | 15,537,400 |
Frequently Asked Questions (FAQ)
According to our data, the company 4basebio does not pay dividends yet, even in 2025.
4basebio shares are traded on the LSE stock exchange under the ticker: 4BB.L. You can buy or trade them through a variety of stock brokers who provide real stock trading services.
According to our data, the recommendation for 4basebio shares is from a total of 2 analysts. The average target price prediction is 1700 GBp per share.
The total number of 4basebio shares on the exchange is 15,471,900.00 shares, which at the current market capitalization gives the company a total valuation of 184,522,160.00 GBp.